These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 25646811)

  • 1. Protein tyrosine phosphatase receptor type O expression in the tumor niche correlates with reduced tumor growth, angiogenesis, circulating tumor cells and metastasis of breast cancer.
    Liu Z; Hou J; Ren L; He J; Sun B; Sun LZ; Wang S
    Oncol Rep; 2015 Apr; 33(4):1908-14. PubMed ID: 25646811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTPRO represses ERBB2-driven breast oncogenesis by dephosphorylation and endosomal internalization of ERBB2.
    Dong H; Ma L; Gan J; Lin W; Chen C; Yao Z; Du L; Zheng L; Ke C; Huang X; Song H; Kumar R; Yeung SC; Zhang H
    Oncogene; 2017 Jan; 36(3):410-422. PubMed ID: 27345410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTPRO-mediated autophagy prevents hepatosteatosis and tumorigenesis.
    Zhang W; Hou J; Wang X; Jiang R; Yin Y; Ji J; Deng L; Huang X; Wang K; Sun B
    Oncotarget; 2015 Apr; 6(11):9420-33. PubMed ID: 25826083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTPRO plays a dual role in hepatic ischemia reperfusion injury through feedback activation of NF-κB.
    Hou J; Xia Y; Jiang R; Chen D; Xu J; Deng L; Huang X; Wang X; Sun B
    J Hepatol; 2014 Feb; 60(2):306-12. PubMed ID: 24128416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival and inflammation promotion effect of PTPRO in fulminant hepatitis is associated with NF-κB activation.
    Jiang R; Chen D; Hou J; Tan Z; Wang Y; Huang X; Wang X; Sun B
    J Immunol; 2014 Nov; 193(10):5161-70. PubMed ID: 25339662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3.
    Hou J; Xu J; Jiang R; Wang Y; Chen C; Deng L; Huang X; Wang X; Sun B
    Hepatology; 2013 Feb; 57(2):678-88. PubMed ID: 22821478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Protein Tyrosine Phosphatase Receptor Type O (PTPRO) as a Synaptic Adhesion Molecule that Promotes Synapse Formation.
    Jiang W; Wei M; Liu M; Pan Y; Cao D; Yang X; Zhang C
    J Neurosci; 2017 Oct; 37(41):9828-9843. PubMed ID: 28871037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation.
    Yu M; Lin G; Arshadi N; Kalatskaya I; Xue B; Haider S; Nguyen F; Boutros PC; Elson A; Muthuswamy LB; Tonks NK; Muthuswamy SK
    Mol Cell Biol; 2012 Oct; 32(19):3913-24. PubMed ID: 22851698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetically silenced PTPRO functions as a prognostic marker and tumor suppressor in human lung squamous cell carcinoma.
    Ming F; Sun Q
    Mol Med Rep; 2017 Jul; 16(1):746-754. PubMed ID: 28586036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fes tyrosine kinase expression in the tumor niche correlates with enhanced tumor growth, angiogenesis, circulating tumor cells, metastasis, and infiltrating macrophages.
    Zhang S; Chitu V; Stanley ER; Elliott BE; Greer PA
    Cancer Res; 2011 Feb; 71(4):1465-73. PubMed ID: 21159660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein tyrosine phosphatase receptor-type O (PTPRO) is co-regulated by E2F1 and miR-17-92.
    Xu X; Hong Y; Kong C; Xu L; Tan J; Liang Q; Huang B; Lu J
    FEBS Lett; 2008 Aug; 582(19):2850-6. PubMed ID: 18644370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein tyrosine phosphatase receptor type O (PTPRO) knockdown enhances the proliferative, invasive and angiogenic activities of trophoblast cells by suppressing ER resident protein 44 (ERp44) expression in preeclampsia.
    Yang Y; Qiu X; Wang F
    Bioengineered; 2021 Dec; 12(2):9561-9574. PubMed ID: 34719307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral expression of mature human neutrophil peptide-1 potentiates the therapeutic effect of doxorubicin in a mouse 4T1 breast cancer model.
    Li D; Qin Q; Wang XY; Shi HS; Luo M; Guo FC; Wang W; Wang YS
    Oncol Rep; 2014 Mar; 31(3):1287-95. PubMed ID: 24378474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTPROt maintains T cell immunity in the microenvironment of hepatocellular carcinoma.
    Hou J; Deng L; Zhuo H; Lin Z; Chen Y; Jiang R; Chen D; Zhang X; Huang X; Sun B
    J Mol Cell Biol; 2015 Aug; 7(4):338-50. PubMed ID: 26117839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered podocyte structure in GLEPP1 (Ptpro)-deficient mice associated with hypertension and low glomerular filtration rate.
    Wharram BL; Goyal M; Gillespie PJ; Wiggins JE; Kershaw DB; Holzman LB; Dysko RC; Saunders TL; Samuelson LC; Wiggins RC
    J Clin Invest; 2000 Nov; 106(10):1281-90. PubMed ID: 11086029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apelin inhibition prevents resistance and metastasis associated with anti-angiogenic therapy.
    Uribesalgo I; Hoffmann D; Zhang Y; Kavirayani A; Lazovic J; Berta J; Novatchkova M; Pai TP; Wimmer RA; László V; Schramek D; Karim R; Tortola L; Deswal S; Haas L; Zuber J; Szűcs M; Kuba K; Dome B; Cao Y; Haubner BJ; Penninger JM
    EMBO Mol Med; 2019 Aug; 11(8):e9266. PubMed ID: 31267692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activating transcription factor 4 promotes angiogenesis of breast cancer through enhanced macrophage recruitment.
    Liu C; Li Z; Wang L; Tong L; He N; Chen Y; Liu Y; Wu Z; Sun P; Xiang R; Ren G; Su W
    Biomed Res Int; 2015; 2015():974615. PubMed ID: 25883982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of ptpro as a novel target gene of Wnt signaling and its potential role as a receptor for Wnt.
    Kim M; Kim H; Jho EH
    FEBS Lett; 2010 Sep; 584(18):3923-8. PubMed ID: 20804755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical role for GRP78/BiP in the tumor microenvironment for neovascularization during tumor growth and metastasis.
    Dong D; Stapleton C; Luo B; Xiong S; Ye W; Zhang Y; Jhaveri N; Zhu G; Ye R; Liu Z; Bruhn KW; Craft N; Groshen S; Hofman FM; Lee AS
    Cancer Res; 2011 Apr; 71(8):2848-57. PubMed ID: 21467168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.